Osteopore Ltd. (AU:OSX) has recently made an announcement about their collaboration with NDCS and A*STAR on an A$18.7m project. The company has been developing a 3D-printed technology for dental implants that promotes bone regeneration, and they have reported significant progress in this area. By combining biological additives with polymer compounds, Osteopore has achieved promising results in terms of non-cytotoxic responses and enhanced osteogenic differentiation. This breakthrough positions Osteopore strongly within the global dental bone graft and membrane substitute market, with plans to move forward with in vivo studies.
For investors interested in learning more about AU:OSX stock, they can find additional insights on TipRanks’ Stock Analysis page.
